View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
Abiogen Pharma|19 February 2019

Business Development and Licensing

Collaborations with major national and international pharmaceutical companies have always represented the core of Abiogen Pharma’s activities, and it is thanks to these relationships that the company was established.

Collaborations with major national and international pharmaceutical companies have always represented the core of Abiogen Pharma’s activities, and it is thanks to these relationships that the company was established.

Networking activity has permitted the optimisation of internal research, licensing out. Partnerships have in fact the goal of strengthening the commercial impact of Abiogen Pharma’s molecules in Italy, and of spreading its presence internationally on those markets where the company is not directly involved.

The licensing out activity is destined to grow in the near future thanks to a large number of projects already in the clinical phase and consequently need to offer them the opportunities for appropriate partnerships in Italy and abroad.

Abiogen focuses its activities also in licensing In, to ensure the dynamic development of the company through the identification and implementation of business opportunities. Abiogen’s vision and business commitment lead to the exploration of strategic opportunities that can advance its product portfolio in therapeutic areas such as the musculoskeletal, diabetology, dermatology and respiratory areas.

Abiogen Pharma is a well-established pharmaceutical company headquartered just outside of Pisa, Italy, that develops and markets medical solutions in primary care and rare diseases...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology